Trademark: 86920447
Word
HYB & SEQ
Status
Dead
Status Code
606
Status Date
Monday, October 14, 2019
Serial Number
86920447
Mark Type
4000
Filing Date
Thursday, February 25, 2016
Published for Opposition
Tuesday, July 19, 2016
Abandoned Date
Monday, October 14, 2019

Trademark Owner History
NanoString Technologies, Inc. - Owner At Publication

Classifications
1 diagnostic reagents for scientific or research use in the field of cancer; diagnostic reagents for scientific research relating to molecular identification and digital quantification; diagnostic reagent kits comprising primarily diagnostic reagents for scientific or research use in the field of cancer; diagnostic test kits for scientific use comprising reagents, slides, solid matrix materials, microfluidic devices and support documentation, namely, instructional manuals, therefor; diagnostic test kits comprising reagents for scientific research relating to molecular identification and digital quantification; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; diagnostic reagents for clinical or medical laboratory use, namely, reagents for proteomics, RNA transcription and microRNA expression profiling, small-molecule analysis, single nucleotide polymorphisms analysis, DNA sequencing, detection of polymorphisms in human fluids, detection of copy number variations, and clinical, oncology, and hematology diagnostics; multiparameter quantitative detection and analysis products and technology for research and diagnostics for a variety of uses in the health care and other life science sectors, namely, reagents for scientific or medical research use, diagnostic preparations and reagents for scientific or research uses, namely, RNA transcription profiling, proteomics, clinical diagnostics, environmental monitoring, biosurveillance, agricultural inspection, forensic testing of samples containing microorganisms or human fluids, small-molecule analysis, single nucleotide polymorphisms analysis, and DNA sequencing; test kits, consisting of chemical preparations for scientific purposes, in particular for the detection, diagnosis, progress monitoring and progress prediction of diseases, including inflammations, infections, disorders of the central nervous systems, cardiovascular, neurological, endocrine, autoimmune and genetic disorders and cancers; assays, reagents, enzymes, polymerases, buffers and nucleotides, and kits comprised thereof, all for scientific or research use; multiparameter quantitative detection and analysis products and technology for research and diagnostics for a variety of uses in life science sectors namely, diagnostic reagents for scientific in vitro use in biochemistry, clinical chemistry and microbiology, RNA and microRNA expression transcription profiling, proteomics, clinical diagnostics, environmental monitoring, agricultural inspection, small-molecule analysis, single nucleotide polymorphisms analysis, and DNA sequencing
5 diagnostic reagents for medical use in the field of cancer; diagnostic reagent kits comprising primarily of diagnostic reagents for medical use in the field of cancer; chemical reagents for medical use; diagnostic test kits for medical use comprising primarily reagents, slides, solid matrix materials, microfluidic devices sold as a unit with instructional manuals therefor; medical diagnostic test kits for detecting pathogens, comprising primarily reagents, slides, solid matrix materials, microfluidic devices sold as a unit and instructional manuals therefor; medical diagnostic kits comprising medical diagnostic reagents for use in detecting the presence of analytes in samples and identifying sample type, and equipment, namely, medical diagnostic immuno-assays for screening samples detecting the presence of analytes in samples and identifying sample type, sold as a unit with instructional manuals; replacement parts for medical diagnostic kits for use in detecting the presence of analytes in samples and identifying sample type in the nature of equipment, namely, medical diagnostic immune-assays for screening samples detecting the presence of analytes in samples and identifying sample type; medical diagnostic reagents for RNA transcription and microRNA expression profiling, proteomics, small molecule analysis, single nucleotide polymorphisms analysis, DNA sequencing, detection of polymorphisms in human fluids, detection of copy number variations, and clinical, oncology, and hematology diagnostics; multiparameter quantitative detection and analysis products and technology for research and diagnostics for a variety of uses in the health care namely, medical diagnostic reagents and diagnostic reagents for clinical or medical laboratory use, diagnostic reagents for medical in vitro use in biochemistry, clinical chemistry and microbiology, RNA and microRNA expression transcription profiling, proteomics, clinical diagnostics, environmental monitoring, agricultural inspection, small-molecule analysis, single nucleotide polymorphisms analysis, and DNA sequencing; tests designed to isolate and extract cells for genetic analysis, namely, reagents for medical diagnostic use; medical diagnostic reagents and assays for testing of body fluids; kits consisting primarily of medical diagnostic reagents and assays for testing of body fluids; reagents in the form of cell markers and molecule markers for medical purposes
9 computer-based apparatus for detection and analysis of gene expression for scientific use; computer-based apparatus for scientific research, namely, for collecting, processing, and taking images of data in connection with scientific or medical research, the use of diagnostic preparations and reagents for scientific or research use, RNA transcription and microRNA expression profiling, proteomics, environmental monitoring, agricultural inspection, small-molecule analysis, single nucleotide polymorphisms analysis, DNA sequencing, detection of polymorphisms in human fluids, detection of copy number variations, analysis of functional pathway gene sets, and monitoring of biofuel production, and prognostic, predictive, clinical, oncology, and hematology diagnostics; scientific research equipment for imaging single molecule reporters; scanning microscopes; fluorescent microscopes; laboratory equipment, namely, fluidics stations, hybridisation ovens, cartridges carriers and replacement parts therefor; scientific research instruments to process and analyze the single molecule reporters to manage and obtain information from the single molecule reporters; computer software to acquire, analyze and manage the biologic data generated; computer software for controlling fluidics station and scanner functions, for capturing fluorescent signals, and for extracting and analyzing data; diagnostic test kits for scientific use comprising microscope slides and microfluidic devices in the nature of electronic analyzers for the transport and analysis of fluid samples by using microfluidic and nanofluidic channels formed on or in a substrate; kits for scientific research use, namely, for use in detecting the presence of analytes in samples and identifying sample type comprising laboratory equipment for screening samples, detecting the presence of analytes in samples and identifying sample types, namely, containers, dishes, microscope slides, plastic bags, swabs, test tubes, vials and wipes for collecting, storing and transmitting samples and specimens; downloadable multimedia file containing diagnostic test kits for scientific use comprising microscope slides and microfluidic devices, reports, test results, research material, worksheets and other non-printed documents and publications relating to scientific research
10 clinical and medical diagnostic instruments, namely, nucleic acid sequencers
HYB AND SEQ

Trademark Events
Oct 15, 2019
Abandonment Notice E-Mailed - No Use Statement Filed
Oct 14, 2019
Abandonment - No Use Statement Filed
Mar 16, 2019
Notice Of Approval Of Extension Request E-Mailed
Mar 15, 2019
Extension 5 Granted
Mar 11, 2019
Extension 5 Filed
Mar 15, 2019
Case Assigned To Intent To Use Paralegal
Mar 11, 2019
Teas Extension Received
Sep 8, 2018
Notice Of Approval Of Extension Request E-Mailed
Sep 6, 2018
Extension 4 Granted
Sep 6, 2018
Extension 4 Filed
Sep 6, 2018
Teas Extension Received
Mar 2, 2018
Notice Of Approval Of Extension Request E-Mailed
Feb 28, 2018
Extension 3 Granted
Feb 28, 2018
Extension 3 Filed
Feb 28, 2018
Teas Extension Received
Feb 20, 2018
Assigned To Examiner
Sep 12, 2017
Notice Of Approval Of Extension Request E-Mailed
Sep 8, 2017
Extension 2 Granted
Sep 8, 2017
Extension 2 Filed
Sep 8, 2017
Teas Extension Received
Mar 7, 2017
Notice Of Approval Of Extension Request E-Mailed
Mar 3, 2017
Extension 1 Granted
Mar 3, 2017
Extension 1 Filed
Mar 3, 2017
Teas Extension Received
Sep 13, 2016
Noa E-Mailed - Sou Required From Applicant
Jul 19, 2016
Official Gazette Publication Confirmation E-Mailed
Jul 19, 2016
Published For Opposition
Jun 29, 2016
Notification Of Notice Of Publication E-Mailed
Jun 10, 2016
Approved For Pub - Principal Register
Jun 9, 2016
Assigned To Examiner
Mar 2, 2016
Notice Of Pseudo Mark E-Mailed
Mar 1, 2016
New Application Office Supplied Data Entered In Tram
Feb 29, 2016
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24